GSK-GLP112753

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus

Medicine or Vaccine (generic name)

albiglutide/metformin

Sponsor Identification Number

GLP112753

Trial Registry Identification Number(#'s)

NCT00838903 2008-007660-41

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112753

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00838903

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-007660-41

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format

Date Added to this Site

November 2014